Latest
SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients
More Medical News
Where medicine is all fun and games
Most Read
Perspectives
木瓜直播
Featured
Weekly News Quiz
You passed medical training, now see if you can pass our weekly quiz
Multi-step, condition-based, and doctor-reviewed resource library for physicians and their patients.See All Medical Journeys >
Meeting Coverage
More From 木瓜直播
Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds
Two cohort studies didn't find significantly greater risk than other drugs in epilepsy
Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero
Public health investigation is closed, but officials haven't provided patient updates
Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more
Social support may be key to improving glycemic control, experts say
But artificial intelligence model needs further validation before release
First-in-class agent unlikely to get another phase III chance in Dravet, Lennox-Gastaut syndromes
New York prosecutors file murder charge
Health news and commentary gathered by 木瓜直播 staff
U.S. News & World Report looked at birthing-friendly practices, health equity, and more
They also had higher odds of having asthma attacks and emergency room visits
Here's what we know so far
Duration of antibiotic treatment about a day shorter than usual in the ICU
Some experts fear he could "make America sick again"
Podcasts
Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines
木瓜直播 reporters offer further insights into recently covered topics
Three physicians face crossroads in patient care
A discussion with the former CEO of the Bill & Melinda Gates Foundation
From the Advisory Board
Experts tackle myths, data bias, and game-changing outcomes of obesity drugs
An examination of what's driving sexual violence against women in medicine
This newly approved testing modality brings challenges and opportunities
Unequal access threatens to worsen disparities
The potential benefits of CAR T-cell therapies still far outweigh the risks